Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

Clinical trial NCT05823714 · UNKNOWN

Trial details

NCT number: NCT05823714
Sponsor: The First Affiliated Hospital of Soochow University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2022-01-20
Primary completion: 2025-01-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.